Jun 15 2012
W.
L. Gore & Associates (Gore) continues its commitment to
improving patient outcomes in hernia patients, with the launch of a
clinical quality improvement (CQI) study for GORE®
DUALMESH® Biomaterial in laparoscopic repair for ventral
hernia patients. Announced at the Abdominal Wall Reconstruction
Conference 2012, taking place in Washington D.C., the CQI study will
focus on ways to improve the patient and physician experiences in
enhancing patient outcomes.
Gore is working with Surgical Momentum to implement the study. The
methodology of continuous quality improvement will be used to support,
analyze and advance patient care. The goal of the CQI study is to
emphasize better communication and coordination between all
stakeholders, to improve clinical results and ultimately the lives of
hernia patients. The teams are working to define the clinical processes,
size of the patient population and outcomes to be measured for the
study. The initial phase is expected to last at least one year.
Introduced in 1993, GORE DUALMESH Biomaterial is a soft, conformable,
ePTFE material that offers a unique, two-surface design intended for
such applications. Improved in 1999 by developing the textured CORDUROY
surface, the biomaterial features two functionally distinct surfaces:
the CORDUROY surface to encourage host tissue incorporation and the
smooth surface to minimize tissue attachment to the material. The Gore
Biomaterial permits the permanent repair of the abdominal wall, has
ingrowth characteristics that mimic normal tissue healing, easily
assumes the conformity of the abdominal wall musculature anatomy and can
be cut easily without fraying. The clinical reputation of GORE DUALMESH
Biomaterial for the repair and reconstruction of ventral hernias is well
known, exceeding 150 peer-reviewed scientific articles published since
1996 and more than 19 years of clinical history.
"The launch of a clinical quality improvement study for GORE DUALMESH
Biomaterial is an example of Gore's commitment to enhancing the quality
of patient care, which is at the core of everything we do," said Ron
Anderson, Business Leader with the General Medical Products Business.
"Gore has served a variety of markets for more than 50 years and remains
dedicated to providing its customers with high-value products that drive
results."
"We are very pleased to be working with Gore Medical on this important
project," said Dr. Bruce Ramshaw, Chief Medical Officer and founder at
Surgical Momentum. "Gore is a leader in medical device innovation and
the company's commitment to improving patient care, coupled with its
corporate culture, is an inspiration."
Source: W. L. Gore & Associates